News Releases

<< Back
Prestige Brands Holdings, Inc. Reports Third Quarter Fiscal 2007 Results

Net Income of $10.6 Million Up 14% on Total Revenues of $80.l Million

IRVINGTON, N.Y.--(BUSINESS WIRE)--Feb. 5, 2007--Prestige Brands Holdings, Inc. (NYSE-PBH), a consumer products company with a diversified portfolio of well-recognized brands, today announced results for the third fiscal quarter and nine month period ended December 31, 2006. Highlights of the quarter include:

  • Net income of $10.6 million, or $0.21 per diluted share, up 14% over the prior year comparable period
  • Total revenues of $80.1 million, slightly higher than the prior year comparable period
  • Free cash flow of $12.4 million was 12% higher than the prior year comparable period
  • Term loan debt reduced by $18.5 million in the third fiscal quarter

Total revenues for the third quarter ended December 31, 2006 were $80.1 million, slightly higher than total revenues of $79.9 million in the prior year comparable period. Excluding the impact of the acquisitions of Chore Boy(R), Dental Concepts and Wartner(R), organic revenue declined by 6%. Chore Boy and Dental Concepts were acquired in October and November 2005, respectively; the Wartner(R) brand was acquired in September, 2006.

Operating income for the third quarter ended December 31, 2006 was $24.5 million, or 1% below the operating income of $24.7 million in the third quarter of fiscal 2006. The decline in operating income period to period resulted primarily from increases in advertising and promotion spending behind key brands.

Net income for the quarter grew 14% to $10.6 million or $0.21 per diluted share over net income of $9.3 million or $0.19 per diluted share for the comparable prior year period. Net income includes a $1.7 million tax benefit resulting from a reduction in the deferred income tax rate from 39.1% to 38.6% as a result of the implementation of certain tax planning strategies.

Q3 Results by Segment

The Company conducts operations through three principal business segments: Over-the-Counter Drug (OTC), Household Products, and Personal Care products.

OTC Drug

Revenues of the over-the-counter drug products segment for the third quarter ended December 31, 2006 were $45.6 million, 8% higher than the prior year comparable period net revenues of $42.1 million. Increases in this segment resulted from sales gains in several key brands including The Doctor's(R), Clear eyes(R), Little Remedies(R), Dermoplast(R) and New Skin(R). These gains were partially offset by sales declines in the Chloraseptic(R) and Compound W(R) brands.

Household Products

Revenues for the household products segment for the third quarter ended December 31, 2006 were $28.7 million, 7% less than the prior year comparable period net revenues of $30.8 million. Comet(R) and Spic and Span(R), the two core brands in this segment, each recorded declines, while Chore Boy(R) experienced increased sales.

The Comet and Spic and Span declines were primarily the result of comparisons against unusually strong year ago shipments, which included pipeline shipments supporting new distribution and significant promotional sales to one dollar store customer. However, both brands continued to post strong consumer consumption gains during the current quarter.

Personal Care

Revenues for the personal care segment for the third quarter ended December 31, 2006 were $5.8 million, 17% less than the prior year comparable period net revenues of $7.0 million. The decline in revenues was generally in line with the Company's expectations.

Free Cash Flow

Free cash flow is a "non GAAP financial measure" as that term is defined by the Securities and Exchange Commission in Regulation G. Free cash flow is presented in this news release because management believes that it is a commonly used measure of liquidity, and is indicative of cash available for debt repayment and acquisitions. The Company defines "free cash flow" as operating cash flow less capital expenditures.

The Company's free cash flow for the quarter ended December 31, 2006 was $12.4 million, composed of operating cash flows of $12.5 million, less capital expenditures of $0.1 million. Free cash flow for the nine month period ended December 31, 2006 was $54.9 million, composed of operating cash flows of $55.3 million, less capital expenditures of $0.4 million. The Company's free cash flow in 2006 is higher than reported net income as a result of the amortization of intangibles, changes in the components of working capital and the relatively low capital expenditures.

During the third fiscal quarter, the Company used free cash flow to reduce its term loan debt by $18.5 million, bringing debt reduction during the nine month period ended December 31, 2006 to a total of $27.4 million. The Company's debt has been reduced to $471.2 million at December 31, 2006, from $498.6 million at March 31, 2006.

Year-To-Date Results

For the nine month period ended December 31, 2006, total revenues of $240.6 million were 11% higher than the prior period results of $216.7 million. Excluding the effects of acquisitions, year-to-date organic sales were up 3%. For the same period, operating income was up 13% largely as a result of the increase in sales, and lower advertising and promotion spending, partially offset by the increase in general and administrative expenses. Net income for the nine month period ended December 31, 2006 was $27.7 million, an increase of 22% over the comparable period last year.

Outlook

The Company expects its full year organic revenue growth will be in line with its previously stated long-term growth range of 3-4%. Total revenues will increase at a greater rate due to acquisitions. Net income is expected to grow less rapidly than total revenue growth.

Conference Call

The Company will host a conference call to review its third quarter and nine month results on Tuesday, February 6th at 8:30am EST. The toll free number is 866-770-7125 within North America and 617-213-8066 from outside North America. The conference pass code is "prestige". Telephonic replays will be available for two weeks following completion of the call and can be accessed at 888-286-8010 within North America and at 617-801-6888 from outside North America. The pass code is 12780289.

About Prestige Brands Holdings, Inc.

Located in Irvington, New York, Prestige Brands Holdings, Inc. is a marketer and distributor of brand name over-the-counter products, personal care and household products sold throughout the U.S. and Canada. Key brands include Compound W(R) wart remover, Chloraseptic(R) sore throat treatment, New-Skin(R) liquid bandage, Clear eyes(R) and Murine(R) eye care products, Little Remedies(R) pediatric over-the-counter products, Cutex(R) nail polish remover, Comet(R) and Spic and Span(R) household products, and other well-known brands.

Forward Looking Statements

Note: This news release contains "forward-looking statements" within the meaning of the federal securities laws and is intended to qualify for the Safe Harbor from liability established by the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" generally can be identified by the use of forward-looking terminology such as "assumptions," "target," "guidance," "outlook," "plans," "projection," "may," "will," "would," "expect," "intend," "estimate," "anticipate," "believe, "potential," or "continue" (or the negative or other derivatives of each of these terms) or similar terminology. The "forward-looking statements" include, without limitation, statements regarding the outlook for Prestige Brands Holdings' market and the demand for its products, earnings per share, future cash flows from operations, future revenues and margin requirement and expansion, the success of new product introductions, growth in costs and expenses, and the impact of acquisitions, divestitures, restructurings and other unusual items, including Prestige Brands Holdings' ability to integrate and obtain the anticipated results and synergies from its acquisitions. These projections and statements are based on management's estimates and assumptions with respect to future events and financial performance and are believed to be reasonable, though are inherently uncertain and difficult to predict. Actual results could differ materially from those projected as a result of certain factors. A discussion of factors that could cause results to vary is included in the Company's Annual Report on Form 10-K and other periodic and other reports filed with the Securities and Exchange Commission.

                    Prestige Brands Holdings, Inc.
                Consolidated Statements of Operations
                             (Unaudited)

                                  Three Months         Nine Months
                               Ended December 31    Ended December 31
                               ------------------  -------------------
  (In thousands, except per
          share data)            2006      2005      2006      2005
                               --------- --------  --------- ---------
Revenues
 Net sales                     $ 79,564  $79,829   $239,164  $216,577
 Other revenues                     560       27      1,434        77
                               --------- --------  --------- ---------
  Total revenues                 80,124   79,856    240,598   216,654
                               --------- --------  --------- ---------

Cost of Sales
 Costs of sales                  36,766   38,726    114,350   103,224
                               --------- --------  --------- ---------
  Gross profit                   43,358   41,130    126,248   113,430
                               --------- --------  --------- ---------

Operating Expenses
 Advertising and promotion        8,952    7,385     25,809    26,307
 General and administrative       7,068    6,159     20,761    15,182
 Depreciation                       177      520        616     1,495
 Amortization of intangible
  assets                          2,627    2,314      7,013     6,610
                               --------- --------  --------- ---------
  Total operating expenses       18,824   16,378     54,199    49,594
                               --------- --------  --------- ---------

  Operating income               24,534   24,752     72,049    63,836
                               --------- --------  --------- ---------

Other income (expense)
 Interest income                    199      144        787       451
 Interest expense               (10,355)  (9,670)   (30,478)  (27,158)
                               --------- --------  --------- ---------
  Total other income (expense)  (10,156)  (9,526)   (29,691)  (26,707)
                               --------- --------  --------- ---------

 Income before provision for
 income taxes                    14,378   15,226     42,358    37,129

 Provision for income taxes       3,735    5,881     14,675    14,481
                               --------- --------  --------- ---------
  Net income                   $ 10,643  $ 9,345   $ 27,683  $ 22,648
                               ========= ========  ========= =========


Basic earnings per share       $   0.21  $  0.19   $   0.56  $   0.46
                               ========= ========  ========= =========

Diluted earnings per share     $   0.21  $  0.19   $   0.55  $   0.45
                               ========= ========  ========= =========

Weighted average shares outstanding:
   Basic                         49,535   48,929     49,425    48,874
                               ========= ========  ========= =========
   Diluted                       50,024   50,010     50,016    50,007
                               ========= ========  ========= =========

                    Prestige Brands Holdings, Inc.
                     Consolidated Balance Sheets
                             (Unaudited)

(In thousands)                               December 31,  March 31,
                                                 2006         2006
                                             ------------ ------------
Assets
Current assets
Cash and cash equivalents                     $    4,802   $    8,200
Accounts receivable                               35,230       40,042
Inventories                                       31,780       33,841
Deferred income tax assets                         2,522        3,227
Prepaid expenses and other current assets          1,466          701
                                             ------------ ------------
Total current assets                              75,800       86,011

Property and equipment                             1,453        1,653
Goodwill                                         303,928      297,935
Intangible assets                                659,784      637,197
Other long-term assets                            11,200       15,849
                                             ------------ ------------

Total Assets                                  $1,052,165   $1,038,645
                                             ============ ============

Liabilities and Stockholders' Equity
Current liabilities
 Accounts payable                             $   20,500   $   18,065
 Accrued interest payable                          4,872        7,563
 Income taxes payable                                211        1,795
 Other accrued liabilities                        10,167        4,582
 Current portion of long-term debt                 3,550        3,730
                                             ------------ ------------
Total current liabilities                         39,300       35,735

Long-term debt                                   467,688      494,900
Other accrued liabilities                          2,801           --
Deferred income tax liabilities                  105,490       98,603
                                             ------------ ------------

Total Liabilities                                615,279      629,238
                                             ------------ ------------

Stockholders' Equity
Preferred stock - $0.01 par value
  Authorized - 5,000 shares
  Issued and outstanding - None                       --           --
Common stock - $0.01 par value
  Authorized - 250,000 shares
  Issued - 50,060 shares at December 31,
   2006 and 50,056 shares at March 31, 2006          501          501
Additional paid-in capital                       379,009      378,570
Treasury stock, at cost - 55 shares at
 December 31, 2006 and 18 shares at March
 31, 2006                                            (40)         (30)
Accumulated other comprehensive income               476        1,109
Retained earnings                                 56,940       29,257
                                             ------------ ------------
Total stockholders' equity                       436,886      409,407
                                             ------------ ------------

Total Liabilities and Stockholders' Equity    $1,052,165   $1,038,645
                                             ============ ============

                    Prestige Brands Holdings, Inc.
                Consolidated Statements of Cash Flows
                             (Unaudited)

                                                   Nine Months Ended
                                                       December 31
                                                   -------------------
(In thousands)                                       2006      2005
                                                   --------- ---------
Operating Activities
Net income                                         $ 27,683  $ 22,648
Adjustments to reconcile net income to net cash
 provided by operating activities:
 Depreciation and amortization                        7,629     8,105
 Deferred income taxes                                7,686    11,543
 Amortization of deferred financing costs             2,422     1,727
 Stock-based compensation                               439       230
Changes in operating assets and liabilities
 Accounts receivable                                  4,812     2,681
 Inventories                                          2,707    (6,997)
 Prepaid expenses and other current assets             (765)      271
 Accounts payable                                     1,366    (3,549)
 Income taxes payable                                (1,584)   (2,135)
 Accrued liabilities                                  2,894     1,312
                                                   --------- ---------
Net cash provided by operating activities            55,289    35,836
                                                   --------- ---------

Investing Activities
Purchases of equipment                                 (429)     (452)
Purchase of intangibles                                  --   (22,623)
Purchase of business                                (30,856)  (30,555)
                                                   --------- ---------
Net cash used for investing activities              (31,285)  (53,630)
                                                   --------- ---------


Financing Activities
Proceeds from the issuance of notes                      --    30,000
Repayment of long-term debt                         (27,392)   (7,797)
Payment of deferred financing costs                      --       (13)
Purchase of common stock for treasury                   (10)      (21)
Additional costs associated with initial public
 offering                                                --       (63)
                                                   --------- ---------
Net cash provided by (used for) financing
 activities                                         (27,402)   22,106
                                                   --------- ---------

Increase (decrease) in cash                          (3,398)    4,312
Cash - beginning of period                            8,200     5,334
                                                   --------- ---------

Cash - end of period                               $  4,802  $  9,646
                                                   ========= =========

Supplemental Cash Flow Information
Fair value of assets acquired                      $ 34,710  $ 33,909
Fair value of liabilities assumed                    (3,854)   (3,354)
                                                   --------- ---------
Cash paid to purchase business                     $ 30,856  $ 30,555
                                                   ========= =========

Interest paid                                      $ 30,749  $ 28,206
                                                   ========= =========
Income taxes paid                                  $  8,790  $  1,335
                                                   ========= =========
                    Prestige Brands Holdings, Inc.
                   Statements of Segment Operations
                             (Unaudited)

                              Three Months Ended December 31, 2006
                           -------------------------------------------
                            Over-the-
                             Counter   Household Personal
                              Drug     Cleaning    Care   Consolidated
                           ----------- --------- -------- ------------
(In thousands)
Net sales                    $ 45,574  $ 28,155  $ 5,835    $  79,564
Other revenues                     --       560       --          560
                           ----------- --------- -------- ------------

Total revenues                 45,574    28,715    5,835       80,124
Cost of sales                  15,800    17,787    3,179       36,766
                           ----------- --------- -------- ------------

Gross profit                   29,774    10,928    2,656       43,358
Advertising and promotion       7,089     1,595      268        8,952
                           ----------- --------- -------- ------------

Contribution margin          $ 22,685  $  9,333  $ 2,388       34,406
                           =========== ========= ========
Other operating expenses                                        9,872
                                                          ------------

Operating income                                               24,534
Other (income) expense                                         10,156
Provision for income taxes                                      3,735
                                                          ------------

Net income                                                  $  10,643
                                                          ============
                               Nine Months Ended December 31, 2006
                           -------------------------------------------
                            Over-the-
                             Counter   Household Personal
                              Drug     Cleaning    Care   Consolidated
                           ----------- --------- -------- ------------
(In thousands)
Net sales                  $  131,427  $ 88,625  $19,112   $  239,164
Other revenues                     --     1,434       --        1,434
                           ----------- --------- -------- ------------

Total revenues                131,427    90,059   19,112      240,598
Cost of sales                  48,198    54,882   11,270      114,350
                           ----------- --------- -------- ------------

Gross profit                   83,229    35,177    7,842      126,248
Advertising and promotion      19,572     5,305      932       25,809
                           ----------- --------- -------- ------------

Contribution margin        $   63,657  $ 29,872  $ 6,910      100,439
                           =========== ========= ========
Other operating expenses                                       28,390
                                                          ------------

Operating income                                               72,049
Other (income) expense                                         29,691
Provision for income taxes                                     14,675
                                                          ------------

Net income                                                 $   27,683
                                                          ============

                    Prestige Brands Holdings, Inc.
                   Statements of Segment Operations
                             (Unaudited)

                              Three Months Ended December 31, 2005
                           -------------------------------------------
                            Over-the-
                             Counter   Household Personal
                              Drug     Cleaning    Care   Consolidated
                           ----------- --------- -------- ------------
(In thousands)
Net sales                   $  42,051  $ 30,771  $ 7,007    $  79,829
Other revenues                     --        27       --           27
                           ----------- --------- -------- ------------

Total revenues                 42,051    30,798    7,007       79,856
Cost of sales                  15,821    18,951    3,954       38,726
                           ----------- --------- -------- ------------

Gross profit                   26,230    11,847    3,053       41,130
Advertising and promotion       4,926     1,735      724        7,385
                           ----------- --------- -------- ------------

Contribution margin         $  21,304  $ 10,112  $ 2,329       33,745
                           =========== ========= ========
Other operating expenses                                        8,993
                                                          ------------

Operating income                                               24,752
Other (income) expense                                          9,526
Provision for income taxes                                      5,881
                                                          ------------

Net income                                                  $   9,345
                                                          ============
                               Nine Months Ended December 31, 2005
                           -------------------------------------------
                            Over-the-
                             Counter   Household Personal
                              Drug     Cleaning    Care   Consolidated
                           ----------- --------- -------- ------------
(In thousands)
Net sales                   $ 116,199  $ 78,783  $21,595   $  216,577
Other revenues                     --        77       --           77
                           ----------- --------- -------- ------------

Total revenues                116,199    78,860   21,595      216,654
Cost of sales                  43,044    47,873   12,307      103,224
                           ----------- --------- -------- ------------

Gross profit                   73,155    30,987    9,288      113,430
Advertising and promotion      18,192     5,245    2,870       26,307
                           ----------- --------- -------- ------------

Contribution margin         $  54,963  $ 25,742  $ 6,418       87,123
                           =========== ========= ========
Other operating expenses                                       23,287
                                                          ------------

Operating income                                               63,836
Other (income) expense                                         26,707
Provision for income taxes                                     14,481
                                                          ------------

Net income                                                 $   22,648
                                                          ============

CONTACT:
For Prestige Brands Holdings, Inc.
Dean Siegal
914-524-6819

SOURCE:
Prestige Brands Holdings, Inc.

Primary IR Contact

Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

AST
6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449
help@astfinancial.com
https://www.astfinancial.com

Subscribe

Stay up to date with investor news, stock information and SEC filings.
Subscribe »